Effect of Post Covid-19 Hypoxia on Placenta of Normal Pregnant Women: A Possible Role of Hypoxia Inducible Factor-1α.
NCT05158868 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50
Last updated 2021-12-15
Summary
To study the risk of hypoxia in placenta of normal pregnant women infected with covid-19 during third trimester of pregnancy.
Conditions
- Hif-1α Covid-19
Interventions
- DIAGNOSTIC_TEST
-
HiF-1 alpha measurement
HIF1- α is a heterodimeric transcription factor that bind to hypoxia response elements, which participates through the regulation of the expression of several genes in numerous cellular events such as O2 sensing, glucose metabolism, lipid metabolism, angiogenesis and other aspects of endothelial biology
Sponsors & Collaborators
-
Assiut University
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 40 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-01-01
- Primary Completion
- 2022-09-30
- Completion
- 2023-06-30
More Related Trials
-
Maternal and Fetal Outcomes in Pregnant Women With COVID -19,a Cross Sectional Study
NCT05608616 ·Status: COMPLETED
-
Prediction of Placenta Accreta Outcome in Pregnant Woman With Placenta Previa Using (hcg_h ) as Abiomarkers
NCT06761885 ·Status: NOT_YET_RECRUITING
-
Effect of Covid 19 Infection on Fetomaternal Outcome
NCT05160649 ·Status: UNKNOWN
-
COVID-19 and Pregnancy: Placental and Immunological Impacts
NCT04726111 ·Status: COMPLETED ·Phase: NA
-
Indicators of Neuronal Insult in Newborns of COVID-19 Positive Mothers.
NCT05175638 ·Status: UNKNOWN
-
COVID-19 on Placental Gene Expression and Pathology
NCT04585945 ·Status: COMPLETED
-
Role of Vaspin in Pathophysiology of Pre-eclampsia
NCT06437535 ·Status: NOT_YET_RECRUITING
-
Improved Characterisation of Eclampsia
NCT05199558 ·Status: UNKNOWN
-
The Investigation of the Prediction Model and Prevention Strategy of Serious Pregnancy Complications in Hypertensive Disorders of Pregnancy Based on the Chinese Population
NCT05089175 ·Status: UNKNOWN
-
Antenatal COVID 19 Vaccination and Pregnancy Outcomes
NCT05401825 ·Status: UNKNOWN
-
Effects of COVID-19 Infection on Pregnancy Outcomes and Offspring Health
NCT06186947 ·Status: RECRUITING
-
Serum LncRNAs as Early Potential Biomarkers for the Prediction of Preeclampsia
NCT03903393 ·Status: UNKNOWN
-
Evaluation of the Possible Vertical Transmission of SARS-CoV-2 Through Study of Amniotic Fluid and Chorionic Villi of Affected Pregnant Women for the COVID-19
NCT04598347 ·Status: UNKNOWN
-
Study on Retroplacental Hematomas in Finistère
NCT04168606 ·Status: COMPLETED
-
The Impact of COVID-19 on Maternal and Neonatal Outcomes
NCT05197621 ·Status: RECRUITING
-
Obstetric and Perinatal Outcomes of Women With COVID-19
NCT04369859 ·Status: COMPLETED
-
Perinatal Outcomes and Hematologic Parameters in COVID-19 Pregnancies
NCT04515108 ·Status: COMPLETED
-
Prediction of Early Pre-eclampsia From Maternal Factors, Biophysical and Biochemical Markers at First Trimester
NCT02990767 ·Status: UNKNOWN
-
State of Coagulation in Pre-eclampsia: Comparing Sonoclot Signature Analysis With Conventional and Specific Haemostasis Assays
NCT05625763 ·Status: UNKNOWN
-
COVID-19 and Pregnancy Outcomes
NCT04416373 ·Status: UNKNOWN
-
Study of Pregnancy Pathologies Associated With Placental Abnormalities
NCT05188066 ·Status: NOT_YET_RECRUITING
-
Screening for Intrapartum Fetal Compromise Using Placental Biomarkers
NCT07258329 ·Status: RECRUITING
-
Cardiovascular an Echocardiographic Assessment in Hypertension During Pregnancy
NCT01068002 ·Status: COMPLETED
-
Proteomics/Modifier Based on Mass Spectrometry Reveals the Pathogenesis of Eclampsia During Pregnancy and the Screening of Disease Markers
NCT04833881 ·Status: UNKNOWN
-
Role and Expression of MXRA5 in Placental Connective Tissue Remodelling in Preeclampsia
NCT04287998 ·Status: UNKNOWN